Keyphrases
Intensive Care
60%
Maastricht
60%
Coronavirus Disease (COVID)
60%
Sarcoidosis
36%
Rotational Thromboelastometry (ROTEM)
36%
Polymorphism
17%
Low Molecular Weight Heparin
16%
COVID-19
15%
Drug-induced
14%
Risk Factors
14%
Critically Ill COVID-19 Patients
13%
Unfractionated Heparin
13%
Dutch
13%
Nephrolithiasis
12%
Risk Stratification
12%
Drug-induced Interstitial Lung Disease
12%
COVID-19 Disease
12%
Critical COVID-19
12%
Heparin Monitoring
12%
Drug-gene
12%
Patient Observation
12%
Comorbidity
12%
Dephosphorylated Uncarboxylated Matrix Gla Protein
12%
Matrix Gla Protein
12%
Vitamin K Epoxide Reductase
12%
Thrombin Generation
12%
Alternative Anticoagulants
12%
Quantra
12%
QPlus
12%
Goal-directed Transfusions
12%
Surgery Patients
12%
Clinical Pattern
12%
Prospective Observational Study
12%
Cardiothoracic Surgery
12%
Transfusion Protocol
12%
Uveitis
12%
National Collaboration
12%
COVID-19 Pandemic
12%
Non-survivors
10%
Drug Use
10%
Fibrinogen
9%
Transfusion
9%
Intensive Care Unit
7%
Tissue Plasminogen Activator (t-PA)
7%
Clotting Time
7%
Intubation
7%
Survivors
7%
Hemostasis
7%
University Medical Centre
7%
Maastricht University
7%
Activated Partial Thromboplastin Time (aPTT)
6%
CT Ratio
6%
Pulmonary Embolism
6%
Intensive Care Unit Mortality
6%
Adverse Drug Reaction
6%
EXTEM
6%
FIBTEM
6%
International Collaboration
6%
Novel Disease
6%
Endotracheal Intubation
5%
Intensive Care Unit Admission
5%
Anti-Xa
5%
INIS
patients
100%
diseases
42%
covid-19
36%
risks
31%
comparative evaluations
28%
units
24%
drugs
24%
mortality
20%
heparin
17%
genetics
15%
vitamin k
15%
genes
15%
proteins
15%
monitoring
14%
levels
13%
design
13%
data
12%
anticoagulants
12%
stratification
12%
matrices
12%
interstitials
12%
applications
12%
lungs
12%
reductases
12%
biological markers
12%
thrombin
12%
exploration
12%
epoxides
12%
surgery
12%
transfusions
12%
appraisal
12%
tissues
11%
fibrinogen
10%
inflammation
9%
plasminogen
9%
molecular weight
8%
adjustments
7%
organs
6%
lysis
6%
coronaviruses
6%
trajectories
6%
evaluation
6%
Medicine and Dentistry
Intensive Care
60%
COVID-19
60%
Thromboelastometry
36%
Sarcoidosis
24%
Intensive Care Unit
22%
Diseases
17%
Observational Study
14%
Heparin
13%
Anticoagulant
12%
Risk Stratification
12%
Kidney Stone
12%
Retinol
12%
Thrombin
12%
Biological Marker
12%
Interstitial Lung Disease
12%
Vitamin K Epoxide Reductase
12%
Thorax Surgery
12%
Matrix Gla Protein
12%
Comorbidity
12%
Critical Appraisal
12%
Low Molecular Weight Heparin
11%
Fibrinogen
9%
Intubation
7%
Tissue Plasminogen Activator
7%
Blood Stasis
7%
Pulmonary Embolism
6%
Adverse Drug Reaction
5%